Linerixibat for treating pruritus in people with primary biliary cholangitis [ID6265]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: 6 January 2027
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [TSID11905] [ID6529]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Norucholic acid for treating primary sclerosing cholangitis [ID6583]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Status:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC